[Serum concentration of pregnancy-associated alpha 2-glycoprotein in cervical cancer (author's transl)].
The serum concentration of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) was determined over a period of up to two years in a group of 77 women with carcinoma of the cervix of different staging. A positive correlation was found between the serum alpha 2-PAG level and the clinical course of the disease in only 31 patients (40.3%). It is concluded that measurement of the concentration of alpha 2-PAG in serum is unlikely to be useful as a means of evaluation of the clinical progress.
D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D011257:Pregnancy Proteins / Q000097:blood*; D011266:Pregnancy-Associated Plasma Protein-A / Q000097:blood*; D002583:Uterine Cervical Neoplasms / Q000378:metabolism*
D011257:Pregnancy Proteins; D011266:Pregnancy-Associated Plasma Protein-A
Das Verhalten der Serumkonzentration des schwangerschaftsassoziierten alpha 2-Glykoproteins (alpha 2-PAG) beim Zervixkarzinom.